138499-01-1 Usage
Uses
Used in Pharmaceutical Industry:
Benzyl N-(4-oxocyclopent-2-en-1-yl)carbamate is utilized as a pharmaceutical compound for its potential biological activities. Carbamate derivatives, in general, have been studied for their diverse therapeutic effects, making benzyl N-(4-oxocyclopent-2-en-1-yl)carbamate a candidate for further exploration in drug development.
Used in Organic Synthesis:
In the realm of organic synthesis, benzyl N-(4-oxocyclopent-2-en-1-yl)carbamate serves as a valuable intermediate. Its unique structure allows it to participate in various chemical reactions, facilitating the creation of new organic compounds.
Used in Chemical Research:
Benzyl N-(4-oxocyclopent-2-en-1-yl)carbamate is applied in chemical research to study the properties and reactivity of carbamate derivatives. Understanding its behavior in different chemical contexts can contribute to the advancement of organic chemistry.
Used in Material Development:
benzyl N-(4-oxocyclopent-2-en-1-yl)carbamate may also find use in the development of new materials, given the versatility of carbamate structures to influence the physical and chemical characteristics of materials.
Used in Drug Discovery:
Benzyl N-(4-oxocyclopent-2-en-1-yl)carbamate is considered in drug discovery processes for its potential to contribute to the creation of novel therapeutic agents, particularly given the broad range of biological activities that carbamates can exhibit.
Check Digit Verification of cas no
The CAS Registry Mumber 138499-01-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,8,4,9 and 9 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 138499-01:
(8*1)+(7*3)+(6*8)+(5*4)+(4*9)+(3*9)+(2*0)+(1*1)=161
161 % 10 = 1
So 138499-01-1 is a valid CAS Registry Number.
138499-01-1Relevant articles and documents
An asymmetric synthesis of (1S, 4R)-4-amino-2-cyclopentenol derivatives
Asami, Masatoshi,Ogawa, Megumi,Inoue, Seiichi
, p. 1563 - 1564 (1999)
A highly enantioselective deprotonation of cis-4-aminocyclopentene oxide derivatives 1 was achieved by using a chiral lithium amide, prepared from (2S,3aS,7aS)-2-(pyrrolidin-1-ylmethyl)-octahydroindole. (1S,4R)-4-Amino-2- cyclopentenol derivative 2 was ob
HIV protease inhibitors useful for the treatment of aids
-
, (2008/06/13)
[From equivalent EP0434365A2] Compounds of the form, A-G-B-B-J wherein A is an amine protecting group or urethane, G a dipeptide isostere substituted with a basic amine nitrogen, B an amino acid or analog thereof, and J a small terminal group are describe
